These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38955249)

  • 21. Nuclear imaging techniques for cardiac amyloidosis.
    Saad JM; Al-Mallah MH
    Curr Opin Cardiol; 2024 Sep; 39(5):389-394. PubMed ID: 38967657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
    Chen W; Dilsizian V
    Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
    Waheed A; Dorbala S
    Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
    Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH
    Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.
    Velaga J; Liew C; Choo Poh AC; Lee PT; Lath N; Low SC; Bharadwaj P
    World J Nucl Med; 2022 Sep; 21(3):173-183. PubMed ID: 36060088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
    Kennel SJ; Jackson JW; Stuckey A; Richey T; Foster JS; Wall JS
    PLoS One; 2024; 19(4):e0301756. PubMed ID: 38578730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in PET-Based Cardiac Amyloid Radiotracers.
    Gallegos C; Miller EJ
    Curr Cardiol Rep; 2020 May; 22(6):40. PubMed ID: 32430600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 29. Illustrative review of cardiac amyloidosis by multimodality imaging.
    Tanaka H
    Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Image Cardiac Amyloidosis: A Practical Approach.
    Dorbala S; Cuddy S; Falk RH
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
    Dietemann S; Nkoulou R
    Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
    Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
    Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
    J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: isolated cardiac amyloidosis: an enigma unravelled.
    Khalid U; Awar O; Verstovsek G; Cheong B; Yellapragada SV; Jneid H; Deswal A; Virani SS
    Methodist Debakey Cardiovasc J; 2015; 11(1):53-8. PubMed ID: 25793032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art.
    Popescu C; Burger IA
    Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future.
    Dorbala S; Kijewski MF
    J Nucl Med; 2023 Nov; 64(Suppl 2):20S-28S. PubMed ID: 37918844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of positron emission tomography in cardiac amyloidosis.
    Saeed S; Saad JM; Ahmed AI; Han Y; Al-Mallah MH
    Heart Fail Rev; 2022 Sep; 27(5):1531-1541. PubMed ID: 34743267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.